Order Article Reprints

Gasmi A, Roubaud G, Dariane C, Barret E, Beauval J-B, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, et al. Overview of the Development and Use of Akt Inhibitors in Prostate Cancer. Journal of Clinical Medicine. 2022; 11(1):160. https://doi.org/10.3390/jcm11010160

Gasmi, Anis, Guilhem Roubaud, Charles Dariane, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Gaëlle Fiard, Gaëlle Fromont, Mathieu Gauthé, and et al. 2022. "Overview of the Development and Use of Akt Inhibitors in Prostate Cancer" Journal of Clinical Medicine 11, no. 1: 160. https://doi.org/10.3390/jcm11010160

Gasmi, A., Roubaud, G., Dariane, C., Barret, E., Beauval, J.-B., Brureau, L., Créhange, G., Fiard, G., Fromont, G., Gauthé, M., Ruffion, A., Renard-Penna, R., Sargos, P., Rouprêt, M., Ploussard, G., & Mathieu, R. (2022). Overview of the Development and Use of Akt Inhibitors in Prostate Cancer. Journal of Clinical Medicine, 11(1), 160. https://doi.org/10.3390/jcm11010160